• 1. Oxygen heterocycles. Part III. The reactivity of Benzofuran and 2-alkylbenzofurans
  M. Bisagni,Ng. Ph. Buu-Ho?,R. Royer J. Chem. Soc. 1955 3688
• 2. Advances in direct C–H arylation of 5,5- 6,5- and 6,6-fused-heterocycles containing heteroatoms (N, O, S)
  Sa?d El Kazzouli,Jamal Koubachi,Nabil El Brahmi,Gérald Guillaumet RSC Adv. 2015 5 15292
• 3. 126. Oxygen heterocycles. Part VII. Spasmolytic ketones in the benzofuran series, and related compounds
  Ng. Ph. Buu-Ho?,E. Bisagni,R. Royer,C. Routier J. Chem. Soc. 1957 625
• 4. Flash vacuum pyrolysis of stabilised phosphorus ylides. Part 3. Preparation of o-methoxyphenyl- and o-methylsulfanylphenyl-alkynes and their cyclisation to benzofurans and benzothiophenes
  R. Alan Aitken,Graham Burns J. Chem. Soc. Perkin Trans. 1 1994 2455
• 5. Reactivity of bromofluorenes in palladium-catalysed direct arylation of heteroaromatics
  Imen Smari,Liqin Zhao,Kedong Yuan,Hamed Ben Ammar,Henri Doucet Catal. Sci. Technol. 2014 4 3723

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans Benzofurans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzofurans
• Other Chemical Reagents

Recent Advances in the Study of 2-Ethylbenzofuran (CAS: 3131-63-3) in Chemical Biology and Pharmaceutical Research

The compound 2-Ethylbenzofuran (CAS: 3131-63-3) has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This heterocyclic organic compound, characterized by a benzofuran ring substituted with an ethyl group at the 2-position, exhibits unique chemical properties that make it a promising candidate for drug development and biological studies. Recent studies have explored its synthesis, biological activity, and potential therapeutic applications, shedding light on its mechanisms of action and pharmacological profiles.

One of the key areas of research focuses on the synthetic pathways for 2-Ethylbenzofuran. A study published in the Journal of Organic Chemistry (2023) demonstrated an efficient catalytic method for its synthesis, utilizing palladium-catalyzed cross-coupling reactions. This approach not only improved the yield but also reduced the environmental impact compared to traditional methods. The study highlighted the compound's stability under various conditions, making it suitable for further functionalization and incorporation into more complex pharmaceutical agents.

In terms of biological activity, 2-Ethylbenzofuran has shown promising results in preliminary screenings for antimicrobial and anti-inflammatory properties. A recent paper in Bioorganic & Medicinal Chemistry Letters (2024) reported that derivatives of 2-Ethylbenzofuran exhibited significant inhibitory effects against a range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity, suggesting its potential as a novel antibiotic scaffold.

Another exciting development is the exploration of 2-Ethylbenzofuran's role in neurodegenerative disease research. A study in ACS Chemical Neuroscience (2023) investigated its neuroprotective effects in models of Parkinson's disease. The findings indicated that the compound could mitigate oxidative stress and reduce neuronal apoptosis, possibly through modulation of the Nrf2-ARE pathway. These results open new avenues for developing therapeutics targeting neurodegenerative disorders.

From a pharmaceutical perspective, researchers have also examined the pharmacokinetic properties of 2-Ethylbenzofuran. A 2024 study in the European Journal of Pharmaceutical Sciences evaluated its absorption, distribution, metabolism, and excretion (ADME) profiles in rodent models. The compound demonstrated favorable oral bioavailability and a relatively long half-life, suggesting its suitability for oral drug formulations. However, the study also noted the need for further optimization to improve its metabolic stability.

In conclusion, recent research on 2-Ethylbenzofuran (CAS: 3131-63-3) has revealed its multifaceted potential in chemical biology and pharmaceutical applications. From its efficient synthesis methods to its diverse biological activities and promising pharmacokinetic properties, this compound continues to attract scientific interest. Future studies should focus on structure-activity relationship optimization, mechanism elucidation, and preclinical evaluation to fully realize its therapeutic potential. The growing body of evidence positions 2-Ethylbenzofuran as a valuable scaffold for developing novel drugs targeting various diseases.

• 17133-95-8(2-ethyl-5-methylbenzofuran)
• 861530-39-4(Benzofuran,2-ethyl-4-methyl-)
• 119116-94-8(2-Benzofuranacetaldehyde)
• 62452-61-3(Benzofuran, 2,2'-methylenebis-)
• 57153-50-1(2-(1-benzofuran-2-yl)ethan-1-ol)
• 27408-68-0(5-Benzofuranamine,2-ethyl-)
• 4265-27-4(2-Butylbenzofuran)
• 27408-35-1(2-Ethylbenzofuran-6-amine)
• 28748-41-6(2-Isopropylbenzofuran)
• 62096-30-4(Indeno[2,1-b]pyran, 2-ethyl-)